|
Simtra BioPharma Solutions
|
Pays
United States |
Secteur Santé |
Description Leading provider of sterile contract manufacturing solutions, parenteral delivery systems and customized support services to the pharmaceutical and biotech industries |
Type de deal Détourage |
Date de l'investissement Sep 2023 |
|
Suven Pharmaceuticals
|
Pays
India |
Secteur Santé |
Description A leader in the India pharma CDMO space |
Type de deal Other |
Date de l'investissement Sep 2023 |
|
ICE Pharma
|
Pays
Italy |
Secteur Santé |
Description A global leader in the production of Ursodeoxycholic Acid (UDCA) used for the treatment of gastric and chronic diseases |
Type de deal Buyout |
Date de l'investissement Sep 2019 |
|
BioDuro
|
Pays
China |
Secteur Santé |
Description A leading global life sciences contract research and development organization |
Type de deal Buyout |
Date de l'investissement Jan 2019 |
|
Zentiva
|
Pays
Czech Republic |
Secteur Santé |
Description A leading European generics pharmaceutical company, offering generic medicines across all key therapeutic areas |
Type de deal Détourage |
Date de l'investissement Sep 2018 |
|
Genoa Healthcare
|
Pays
United States |
Secteur Santé |
Description Largest specialty pharmacy operator in the US focusing primarily on serving the needs of the mental health community |
Type de deal Buyout |
Date de l'investissement Apr 2015 |
|
Mediq
|
Pays
Netherlands |
Secteur Santé |
Description Global provider of pharmaceuticals, medical devices and related care services |
Type de deal Public-to-private |
Date de l'investissement Feb 2013 |
|
Grupo Biotoscana
|
Pays
Colombia |
Secteur Santé |
Description Specialty pharmaceutical company licensing innovative and niche products to market in Latin America |
Type de deal Buyout |
Date de l'investissement Nov 2011 |
|
Laboratorio LKM
|
Pays
Argentina |
Secteur Santé |
Description One of the leading specialty pharmaceutical manufacturers in Argentina |
Type de deal Buyout |
Date de l'investissement Oct 2011 |
|
Labormed
|
Pays
Romania |
Secteur Santé |
Description Romanian pharmaceutical manufacturer and distributor |
Type de deal Buyout |
Date de l'investissement Feb 2008 |
|
Terapia
|
Pays
Romania |
Secteur Santé |
Description Romania's largest independent generic pharmaceuticals manufacturer |
Type de deal Public-to-private |
Date de l'investissement Aug 2003 |
|
Aviagen
|
Pays
United Kingdom |
Secteur Santé |
Description World's leading meat poultry breeding company |
Type de deal Buyout |
Date de l'investissement May 2003 |
|
Viatris
|
Pays
Germany |
Secteur Santé |
Description Development, manufacturing, distribution and in-licensing of branded pharmaceuticals |
Type de deal Détourage |
Date de l'investissement Aug 2002 |
|
Fada Pharma
|
Pays
Argentina |
Secteur Santé |
Description Argentina's leading manufacturer of generic pharmaceuticals for the institutional market |
Type de deal Buyout |
Date de l'investissement Jan 2001 |
|
Tropon
|
Pays
Germany |
Secteur Santé |
Description Toll manufacturer and supplier of drugs for inflammatory and rheumatoid disorders (acquired by Advent portfolio company Viatris) |
Type de deal Détourage |
Date de l'investissement Mar 2000 |
|
Alcala Farma
|
Pays
Spain |
Secteur Santé |
Description Manufacturer and marketer of own and in-licensed pharmaceuticals, branded generics and over-the-counter products |
Type de deal Growth equity |
Date de l'investissement Sep 1999 |
|
Trinity Pharmaceuticals
|
Pays
United Kingdom |
Secteur Santé |
Description Co-development, licensing and marketing of branded pharmaceuticals, mainly for cardiovascular and arthritic indications |
Type de deal Détourage |
Date de l'investissement Mar 1997 |
|
3i - Implant Innovations Inc.
|
Pays
United States |
Secteur Santé |
Description Manufacturer of dental implants |
Type de deal Growth equity |
Date de l'investissement May 1995 |
|
Telik
|
Pays
United States |
Secteur Santé |
Description Developer of novel pharmaceuticals to treat cancer and metabolic diseases (merged with MabVax Therapeutics) |
Type de deal Growth equity |
Date de l'investissement Nov 1994 |
|
Esaote Biomedica
|
Pays
Italy |
Secteur Santé |
Description Research, production and marketing of imaging and non-imaging medical diagnostic equipment |
Type de deal Privatization |
Date de l'investissement Jul 1994 |
|
Transcend Therapeutics
|
Pays
United States |
Secteur Santé |
Description Company formed to develop novel pharmaceuticals for the critical-care market |
Type de deal Growth equity |
Date de l'investissement Apr 1994 |